Literature DB >> 29406979

Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis.

William J Muller1, Ellen G Chadwick2.   

Abstract

Exposures that carry risk of transmission of blood-borne disease are rare in pediatrics, but expose patients and families to great anxiety. Specialists in pediatric infectious diseases are often asked about initial antimicrobial prophylaxis in these cases. Guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus have evolved as new formulations and medications become available and greater experience obtained in assessing relative risks of different exposures and relative costs and benefits for different interventions. This article discusses the evidence behind recent updates to Centers for Disease Control and Prevention guidelines for nonoccupational postexposure prophylaxis for human immunodeficiency virus, focusing on application in the pediatric population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antivirals; Blood-borne infections; Human immunodeficiency virus; Needlestick; Postexposure prophylaxis

Mesh:

Substances:

Year:  2018        PMID: 29406979     DOI: 10.1016/j.idc.2017.10.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  1 in total

1.  "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis.

Authors:  Rachel L Epstein; Nicole Penwill; Diana F Clarke; Sebastian Hamilton; Kevin Horbowicz; David Dorfman; James M Moses; Ellen R Cooper
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.